| Literature DB >> 28092083 |
Federica Bono1, Paola Savoia2, Adele Guglielmi2, Massimo Gennarelli3,4, Giovanna Piovani3, Sandra Sigala2, Damiana Leo5, Stefano Espinoza5, Raul R Gainetdinov5,6,7, Paola Devoto8, PierFranco Spano2,9, Cristina Missale2,9, Chiara Fiorentini2.
Abstract
The role of dopamine D2 and D3 receptors (D2R/D3R), located on midbrain dopaminergic (DA) neurons, in the regulation of DA synthesis and release and in DA neuron homeostasis has been extensively investigated in rodent animal models. By contrast, the properties of D2R/D3R in human DA neurons have not been elucidated yet. On this line, the use of human-induced pluripotent stem cells (hiPSCs) for producing any types of cells has offered the innovative opportunity for investigating the human neuronal phenotypes at the molecular levels. In the present study, hiPSCs generated from human dermal fibroblasts were used to produce midbrain DA (mDA) neurons, expressing the proper set of genes and proteins typical of authentic, terminally differentiated DA neurons. In this model, the expression and the functional properties of the human D2R/D3R were investigated with a combination of biochemical and functional techniques. We observed that in hiPSC-derived mDA neurons, the activation of D2R/D3R promotes the proliferation of neuronal progenitor cells. In addition, we found that D2R/D3R activation inhibits nicotine-stimulated DA release and exerts neurotrophic effects on mDA neurons that likely occur via the activation of PI3K-dependent mechanisms. Furthermore, D2R/D3R stimulation counteracts both the aggregation of alpha-synuclein induced by glucose deprivation and the associated neuronal damage affecting both the soma and the dendrites of mDA neurons. Taken together, these data point to the D2R/D3R-related signaling events as a biochemical pathway crucial for supporting both neuronal development and survival and protection of human DA neurons.Entities:
Keywords: Development; Dopamine D2/D3 receptor; Neurodegeneration; Neuroplasticity; Nicotine; hiPSC
Mesh:
Substances:
Year: 2017 PMID: 28092083 DOI: 10.1007/s12035-016-0376-3
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.590